Category: Insights

Get single drug patent reports at DrugPatentWatch

Many readers have been asking for a simple way to get information on just a few drugs. While we do offer short-term three-month subscriptions, there is still a demand for…
The post Get single drug patent reports at DrugPatentWatch appeared first …


Estimated costs of production and potential prices for the WHO Essential Medicines List

This article was originally published by Andrew M Hill, Melissa J Barber, and Dzintars Gotham in BMJ Global Health Jan 2018, 3 (1) e000571 under a Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license. Abstract Introduction There are persi…


Decision-making in product portfolios of pharmaceutical research and development – managing streams of innovation in highly regulated markets

This article was originally published by Antti Jekunen in Drug Des Devel Ther. 2014; 8: 2009–2016 under a Creative Commons Attribution – Non Commercial (unported, v3.0) License. Abstract Decision-making is a core function…
The post Decision-makin…


Biobetters, Supergenerics Hold Many Advantages for Pharma Companies

By Larry Ramer, DrugPatentWatch writer A growing number of pharmaceutical companies are looking to simultaneously benefit from the low costs of developing generic treatments and the increased market share and…
The post Biobetters, Supergenerics H…


8 Applications of Machine Learning in The Pharmaceutical Industry

By Pankaj Mondal, DrugPatentWatch writer Machine learning, the most fundamental form of artificial intelligence, has started infiltrating the medical field, and it seems machines can play a crucial role in…
The post 8 Applications of Machine Lear…


FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars

By Ed Lamb, DrugPatentWatch writer Under a new commissioner dedicated to bolstering competition to reduce prices, the agency is redoing a raft of rules and guidances to speed ANDA approvals…
The post FDA Pushes to Reduce Single-Source Generics, I…


Is importing drugs a risky affair?

The FDA was established to ensure the safety of food and medicines sold in the US. Sadly, the original charter is now slowly being affected by the advocates of drug…
The post Is importing drugs a risky affair? appeared first on DrugPatentWatch.


Obstacles and opportunities in Chinese pharmaceutical innovation

This article was originally published by Jingyun Ni, Junrui Zhao, Carolina Oi Lam Ung, Yuanjia Hu, Hao Hu and Yitao Wang in Globalization and Health201713:21 under a Creative Commons License. Abstract…
The post Obstacles and opportunities in Chin…


Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics

Originally published by  J. Javier Hernandez, Michael Pryszlak, Lindsay Smith, Connor Yanchus, Naheed Kurji, Vijay M. Shahani and Steven V. Molinski in Front. Oncol., 14 November 2017. Abstract The repositioning or…
The post Giving Drugs a Second…


How is biotech combating these five killer diseases on the planet?

Biotechnology is a massive scientific field that uses research tools from biology and chemistry to solve problems and that includes human diseases too. Ever since its existence, it has revolutionized…
The post How is biotech combating these five …


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: